Professional Documents
Culture Documents
Department of Plastic Reconstructive and Aesthetic Surgery, Hand- and Microsurgery, Burn Center,
University Hospital Campus Gasthuisberg, Catholic University of Leuven, 3000 Leuven, Belgium
b
Department of Dermatology, University Hospital Campus St. Raphael, Catholic University of Leuven,
3000 Leuven, Belgium
Abstract Autologous skin grafts are successfully used to close recalcitrant chronic wounds especially at
the lower leg. If wound care is done in a dermato-plastic team approach using the bintegrated concept,Q
difficulties associated with harvesting the skin graft as well as the complexities associated with inducing
closure at the donor and the recipient site can be minimized.
In the context of wound healing, skin transplantation can be regarded as (1) a supportive procedure for
epithelialization of the wound surface and (2) mechanical stability of the wound ground. By placing skin
grafts on a surface, central parts are covered much faster with keratinocytes. Skin (wound) closure is the
ultimate goal, as wound closure means resistance to infection. Depending on the thickness of the skin graft,
different amounts of dermis are transplanted with the overlying keratinocytes. The dermal component
determines the mechanical (resistance to pressure and shear forces, graft shrinkage), functional
(sensibility), and aesthetic properties of the graft. Generally speaking, the thicker the graft the better the
mechanical, functional, and aesthetic properties, however, the worse the neo- and revascularization.
Skin grafts do depend entirely on the re- and neovascularization coming from the wound bed. If the wound
bed is seen as a recipient site for tissue graft, the classification of Lexer (Die freien Transplantationen.
Stuttgart: Enke; 1924) turned out to be of extreme value. Three grades can be distinguished: bgood wound
conditions,Q bmoderate wound conditions,Q and binsufficient wound conditions.Q Given good wound
conditions, skin grafting is feasible. Nevertheless, skin closure alone might not be sufficient to fulfill the
criteria of successful defect reconstruction. In case of moderate or insufficient wound conditions, wound
bed preparation is necessary. If wound bed preparation is successful and good wound conditions can be
achieved, skin grafting is possible. If, however, this attempt is unsuccessful and moderate or binadequate
wound conditionsQ are persisting, other methods of defect reconstruction such as local flap transfer, distant
flap transfer, free (microvascular) flaps, and ultimately amputation must be considered.
D 2005 Elsevier Inc. All rights reserved.
344
R. Hierner et al.
Wound healing
Table 2
Nursing
Internal medicine
Endocrinology
Geriatry
Criteria
Goal
Quality
1. Temporary
wound closure
Assistance to impaired
wound healing
(palliative indication)
Prevention of infection
Prevention of loss
of body fluid(s)
Cure of impaired
wound healing
(curative indication)
Reconstruction
of function
Early mobilization
Integrity of body scheme
Minimal
requirements
2. Complete
wound closure
3. Persistent
wound closure
4. Functional
reconstruction
5. Acceptable
aesthetic result
6. Acceptable length Social reintegration
of time for
rehabilitation and
return to normal life
7. Minimal physical
Quality of life
and/or psychologic
patient impairment
8. Acceptable costs
Cost effectiveness
of treatment
Basic
requirements
Standard
requirements
Rehabilitation
Physiotherapy
Occupational
therapy
Technical
orthopedics
Home-nursing patient
general practitioner
Microbiology
Dermatology
Vascular center
Anesthesiology
Intensive care
Pain
Directors
Hospital financial
service
Public relations
Social service
Plastic surgery
Industry
Pharmacy
Patient group
Basic research
PC support
Facultative members
Oncology
Head and
Neck Center
Psychiatry
Pathology
Orthopedic Surgery
Radiology
Others
Table 1
healing
Advanced
requirements
2.
3.
Defect-related factors
For an exact defect analysis, description of the defect by
looking at etiology, extent, localization, mechanical strain,
and wound conditions is necessary.
Soft tissue defects can be classified into acute and
chronic defects. Acute soft tissue injuries are usually the
result of high-speed accidents, falls from a height, burns, or
gunshot wounds. Because of their diagnostic and therapeutic problems, 2 special cases of acute soft tissue injuries
must be regarded separately: (1) soft tissue defects in a
polytraumatized patient and (2) combined soft tissue and
bone defects. Chronic soft tissue defects are most often
caused by vascular insufficiency (arterial and/or venous),
metabolic disorders (diabetes, etc), chronic infection (ie,
osteomyelitis), irradiation, scarring after multiple surgery,
and neurologic deficits.
In case of a clinically apparent soft tissue insufficiency,
the first step to do is to define whether there is only soft
tissue retraction caused by the inherent elasticity or a real
soft tissue loss. If skin and subcutaneous tissue are missing,
we are speaking of a type A defect. A type B defect is
defined as loss of skin, muscle, and other soft tissue without
bone injury. Further subclassification for bony loss is done
by the AO classification. A combined soft tissue and bone
injury is called a type C defect.3
Localization of the defect is very important with regard
to the mechanical and aesthetic requirements. Concerning
the mechanical load, the so-called low-resistance zones at
the forearm (olecranon, proximal ulna, distal lower
forearm third), hand (dorsum of the hand and fingers),
dorsal pelvic region, lower leg (proximal tibia plateau,
distal lower leg third), and foot have to be taken into
account as (1) they are not bpaddedQ with muscles and (2)
are located in mechanically heavily loaded regions. Even
with good wound conditions, simple skin grafting should
not be carried out for definitive defect coverage, as
unstable scar formation will result in an important amount
of patient.
The judgment of the wound condition is based on
anatomic, physiologic, clinical, and microbiologic facts.
When judging the anatomical criteria, one must check
whether vessels and/or nerves are exposed, tendons are
denuded of peritendineum, bone stripped of periosteum,
345
Therapy-related factors
A variety of factors can be summarized under the term
therapy-related factors, such as different treatment options,
donor defect vs recipient site benefit, surgeons experience,
and equipment available.
Apart from primary or secondary wound closure, the
resources available include simple skin grafting (full
thickness, split thickness, mesh graft), local flap transfer,
distant flap transfer, free (microvascular) flaps, and ultimately amputation.26-30
The benefit at the recipient site must outweigh the donor
site defect. If several donor sites are available one should
chose the less conspicuous especially in women and
children. Preexisting scar can limit the number of treatment
options. In the extremities the mobility of all joints must be
kept in mind to avoid iatrogenic joint stiffness.
The surgeons experience and the available instruments
and facilities play a decisive role in the selection of the
boptimal treatmentQ for the individual case.
Patient-related factors
The most important consideration of treatment is the
patient him/herself, not the soft tissue defect. Therefore, to
select the optimal treatment option it is necessary to take
into account a variety of patient-related factors such as
general health, biological age, professional and leisure time
activities, intelligence, compliance, social environment,
subjective wishes, and so on. With the wrong patient, even
a perfectly done bhigh-technologyQ reconstruction will lead
to an unsatisfactory result.
Skin grafting
Skin grafting is an old technique that goes back to the
ancient Indians. Rediscovered at the end of the 19th century,
skin grafting became the most important treatment of
wound closure during the first and second world
wars.3,6,26,27,29-31
Nowadays, skin grafting experiences a second renaissance in the context of modern wound healing and tissue
engineering. In this context, skin transplantation can be
regarded as a supportive procedure for epithelialization of
the wound surface. By placing skin grafts on a surface,
central parts are covered much faster with keratinocytes.
Skin (wound) closure is the basic goal, as wound closure
means resistance to infection and no more loss of body fluid
and proteins. Skin closure alone in the sense of bsealing the
346
Table 3
patientQ
R. Hierner et al.
Checklist for decision making for the bindividual
1. Basic knowledge
Anatomy (vascularization)
Pathophysiology
2. Defect-related factors
Etiology
Extent
Localization
Mechanical strains
Wound conditions classified by Lexer6good/moderate/
insufficient
Anatomic facts
Covered/exposed vessels, nerves
Spared/injured peritendineum
Spared/injured periosteum
Open/closed joints
Pathophysiologic facts
Vascularization
Clinical facts
Color of the wound
Amount and type of secretion
Microbiologic facts (bacterial balance)
Amount and type of culture
3. Therapy-related factors
Different treatment options
Spontaneous wound healing (healing by secondary intention)
Wound closure (primary, secondary)
Skin grafting (full thickness, split thickness, mesh graft)
Local flaps
Distant flaps
Free (microvascular) flaps
Amputation
Donor defect vs recipient site benefit
Emergency vs planned surgery
Surgeons experience
Equipment available
4. Patient-related factors
General health (blife before limbQ)
Biological age
Intelligence
Gender
Subjective wishes and needs
Profession
Social environment
Compliance
Clinical classification
For clinical use, skin grafts can be classified according a
variety of criteria, with the most commonly used being (1)
thickness of skin graft, (2) geometry of skin graft, (3)
source of graft, (4) nature of graft, and (5) grafting
technique (Table 4).
According to the thickness of the skin graft, splitthickness skin grafts (STSGs) and full-thickness skin grafts
are the most commonly distinguished (Fig. 1).
Split-thickness skin grafts comprised the epidermis and
different amounts of dermis. With regard to the thickness of
the skin graft, different types of skin grafts can be
distinguished: thin STSG (0.2 mm), middle STSG (0.4
mm), and thick STSG (0.6 mm) (Fig. 2a, b).
Full-thickness skin graft contains epidermis and dermis
(Fig. 3a-d).
Depending on the thickness of the skin graft, different
amounts of dermis are transplanted with the overlying
keratinocytes. The dermal component determines the
Table 4
Fig. 1
347
348
R. Hierner et al.
Fig. 3 Defect coverage of a small venous ulcus at the lower leg in a 72-year-old patient with chronic polyarthritis and long-standing
cortisone therapy with a full-thickness skin graft taken from the left groin. a, Clinical aspect at admission. b, Intraoperative view fixation of
the full-thickness skin graft. c, Postoperative view of the donor site at the left groin. d, Clinical aspect after full-thickness skin grafting.
Full-thickness grafts
Advantages
Advantages
It is quick and simple to cut. It is less liable to contraction.
The graft is of uniform
It is more resistant to
thickness and the cut
mechanical wear.
surface is smooth.
It is also successful in a
A subcutaneous layer
contaminated recipient bed. develops beneath the graft
Its size is unlimited.
resulting in a looser and
The donor site heals
more mobile surface.
quickly and spontaneously.
The graft retains its color.
The donor site can be
reused after 1 to 2 months. Disadvantages
It survives only in an aseptic
Disadvantages
bed of good blood supply
It is more liable to contraction Its size is limited.
(approximately 30%).
The donor area must be
It can have unpredictable
closed or covered.
changes of color
(hyper- or hypopigmentation)
349
Fig. 4 Multistage defect coverage of a chronic wound at the right forearm in a patient with long-standing drug abuse. a, Clinical aspect at
admission. b, Intraoperative view after initial debridement. c, Application of VAC (topical negative pressure) system (KCI, Benelux) for
wound bed preparation. d, Clinical aspect after VAC application 1 week after debridement. e, Clinical aspect after split-thickness skin grafting
(mesh graft 1:1.5).
350
R. Hierner et al.
Table 6
351
Fig. 5 Donor sites for STSG (gray) and full-thickness skin grafts
(black). a, anterior view. b, posterior view.
References
1. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method
for wound control and treatment: clinical experience. Ann Plast Surg
1997;38:563 - 76.
2. Falanga V. Classification for wound bed preparation and simulation of
chronic wounds. Wound Repair Regen 2000;8:347 - 52.
3. Hierner R, Berger A. Prinzipien der Defektdeckung. In: Berger A,
Hierner R, editors. Plastische Chirurgie, Band I Grundlagen, Prizipien,
Techniken. Berlin7 Springer; 2002. p. 262 - 312 [chapter 17].
4. McGregor IA. Fundamental techniques of plastic surgery and their
surgical application. 7th ed. Edinburgh7 Churchill Livingstone; 1980.
5. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound.
Clin Plast Surg 1998;25:341 - 56.
352
6. Lexer E. Die freien Transplantationen. Stuttgart7 Enke; 1924.
7. Carrel A, Guthrie C. The reversal of circulation in a limb. Ann Surg
1906;43:203 - 15.
8. Cormack GC, Lamberty BGH. The arterial anatomy of skin flaps.
2nd ed. Edinburgh7 Churchill Livingstone; 1994. p. 1-538.
9. Horstmann E. Die Haut. In: von Mfllendorf W, Bargmann W, editors.
Handbuch der mikroskopischen Anatomie des Menschen 3. Bd. 3 Teil:
Haut und Sinnesorgane. Berlin7 Springer; 1957.
10. Manchot C. Die Hautarterien des menschlichen Kfrpers. Leipzig7
Vogel; 1889.
11. Pearl RM, Johnson D. The vascular supply of the skin. An anatomical
and physiological reappraisal, part 1. Ann Plast Surg 1983;11:99 - 105.
12. Reinisch JF. The pathophysiology of skin flap circulation. The delay
phenomenon. Plast Reconstr Surg 1974;54:585 - 98.
13. Salmon M. Les arteres cutanees. Paris7 Masson; 1936.
14. Taylor GI, Palmer JH, MacManamny D. The vascular territories of the
body (angiosomes) and their clinical applications. In: McCarthy JG,
editor. Plastic surgery, vol. 1. Philadelphia7 Saunders; 1990. p. 329 - 78.
15. Borges AF. Elective incisions and scar revision. Boston7 Little Brown;
1973.
16. Gibson T, Kennedi RM. Biomechanimal properties of skin. Clin North
Amer 1967;47:279 - 83.
ber die Spaltbarkeit der Cutis. Sitzber Dtsch Akad Wiss
17. Langer K. U
Berl Kl Med Wiss 1881;45:233.
18. Agren MS, Eaglstein WH, Ferguson MWJ. Causes and effects of the
chronic inflammation in venous leg ulcers. Acta Derm Venereol
2000;210(Suppl):3 - 17.
19. Davies CE, Wilson MJ, Hill KE, et al. Use of molecular techniques to
study microbial diversity in the skin: chronic wounds reevaluated.
Wound Repair Regen 2001;9:332 - 40.
20. Dow G, Browne A, Sibbald RG. Infection in chronic wounds:
controversies in diagnosis and treatment. Ostomy/Wound Manage
1999;45:23 - 40.
21. Gftz F. Staphylococcus and biofilms. Mol Microbiol 2002;43:1367 - 78.
22. Hannson C, Hoborn J, Mfller A, Swanbeck G. The microbiological
flora in venous leg ulcers without clinical signs of infection. Acta Derm
Venereol 1995;75:24 - 30.
23. Krimmer V, Merkert H, von Eif C, et al. Detection of Staphylococcus
aureus and Staphylococcus epidermidis in clinical samples by 16S
rRNA-directed in situ hybridization. J Clin Microbiol 1999:2667 - 73.
24. Majewski W, Cybulski Z, Napierala M. The value of quantitative
bacteriological investigations in the monitoring of treatment of
ischemic ulcerations of lower legs. Int Angiol 1995;14:381 - 4.
25. Steer JA, Papini RP, Wilson AP, McGrouter DA, Parkhouse N.
Quantitative microbiology in the management of burn patients. II
Relationship between bacterial counts obtained by burn wound biopsy
culture and surface alginate swab culture, with clinical outcome following burn surgery and change of dressings. Burns 1996;22:177 - 81.
26. Andina F. Die freien Hauttransplantationen. Berlin7 Springer; 1970.
27. Berger A, Burke JF. Hauttransplantation oder kqnstlicher Hautersatz?
Zentbl Chir 1988;113:751 - 7.
R. Hierner et al.
28. Gonzalez-Ulloa M. Restoration of the face covering by means of
selected skin in regional aesthetic units. Br J Plast Surg 1954;13:151.
29. Tagliacozzi G. De curtorum chirugia per insitionem. Venice7 Bindoni;
1597.
30. Zoltan J. Atlas of skin repair. Budapest7 Akademiai Kiado; 1984.
31. Hamilton FH. Elkoplasty or anaplasty applied to the treatment of old
ulcers. New York7 Holman & Gray; 1854.
32. Macomber WB, Patton HS. Improved grafting technique for burns of
the extremity. Am J Surg 1947;73:684.
33. Tanner JC, Vandeput J, Olley JF. The mesh skin graft. Plast Reconstr
Surg 1964;34:287.
34. Meek CP. Successful microdermagrafting using the Meek-Well microdermatome. Am J Surg 1958;96:557.
35. Reverdin JL. De la greffe epieermique. Arch Gen Med 1869;8:12.
36. Annoni F, Rosina M, Chiurazzi D, Ceva M. The effects of a
hydrocolloid dressing on bacterial growth and the healing process of
leg ulcers. Int Angiol 1989;8:224 - 8.
37. Grinelli F, Zhu M. Fibronectin degradation in chronic wounds depends
on the relative level of elastase alpha 1-proteinase inhibitor, and
alpha2-macroglobulin. J Invest Dermatol 1996;106:335 - 41.
38. Jung W, Winter H. Considerations for the use of clostridial collagenase
in clinical practice. Clin Drug Investig 1998;15:245 - 52.
39. Kennedy KI, Tritch DL. Debridement. In: Krasner D, Kane D, editors.
Chronic wound care: a clinical source book for healthcare professionals, 2nd ed. Wayne (PA)7 Health Management Publications Inc.;
1997. p. 336 - 43.
40. Mekkes J. Autolytic debridement. In: Chery GW, Harding KG, Ryan
TJ, editors. Wound bed preparation. International Congress and
Symposium Series 250. London7 The Royal Society of Medicine
Press; 2002. p. 14-24.
41. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuumassisted closure: a new method for wound control and treatment:
animal studies and basic foundation. Ann Plast Surg 1997;38:553 - 62.
42. Sherman RA, Hall MJ, Thomas S. Medicinal maggots: an ancient
remedy for some contemporary afflictions. Annu Rev Entomol
2000;45:55 - 81.
43. Sibbald RG, Williamson D, Orsted HL, et al. Preparing the wound
beddebridement, bacterial balance and moisture balance. Ostomy
Wound Manage 2000;46:14 - 35.
44. Thomas S, Jones M, Jones S. Using larvae in modern wound
management. J Wound Care 1996;5:60 - 9.
45. Trengove NJ, Langton SR, Stacey MC. Biochemical analysis of wound
fluid from non-healing and healing chronic leg ulcers. Wound Repair
Regen 1996;4:234 - 9.
46. Wound fluid from chronic leg ulcers contains elevated levels of
metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993;101:
64 - 8.
47. Ziegler UE. Enzymatic debridement. In: Chery GW, Harding KG, Ryan
TJ, editors. Wound bed preparation. International Congress and
Symposium Series 250. London7 The Royal Society of Medicine
Press; 2002. p. 55-68.